Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis
ETI normalized IUS parameters and significantly improved pancreatic stiffness, gastrointestinal symptoms, glycemic control, and cholesterol metabolism in pwCF.
Authors
- Giovanni Casazza (ORCID: https://orcid.org/0000-0003-3718-1784)
- Carla Maria Colombo (ORCID: https://orcid.org/0000-0003-0716-481X)
- Mirella Fraquelli (ORCID: https://orcid.org/0000-0002-7445-1328)
- Fabiola Corti
- Chiara Lanfranchi
- Alessandra Piagnani
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2025-10-24
- DOI
- https://doi.org/10.14309/ctg.0000000000000931
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00